Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 69 publications
Prospective HIV RNA screening with long-acting cabotegravir pre-exposure prophylaxis in HPTN 083.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: March 04, 2026
Estimation of Prevention-Effective CAB-LA Concentrations Among Men Who Have Sex With Men (MSM) and Transgender Women (TGW) in HPTN 083.
Journal: The Journal of infectious diseases
Published: August 27, 2025
Sustained HIV Suppression With Co-formulated Tenofovir Disoproxil Fumarate/Lamivudine/Dolutegravir in a Person With Transmitted Dolutegravir Resistance and Pretreatment Resistance to Lamivudine: a Case Report From HPTN 083.
Journal: Open forum infectious diseases
Published: May 19, 2025
Evaluation of pharmacokinetic interactions between long-acting cabotegravir or emtricitabine/tenofovir disoproxil fumarate and hormonal contraceptive agents: a tertiary analysis of South African participants in HPTN 084.
Journal: Journal of the International AIDS Society
Published: April 03, 2025
Cabotegravir Maintains Protective Efficacy in the Setting of Bacterial Sexually Transmitted Infections: A Secondary Analysis of HPTN 083.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: September 16, 2024
Cabotegravir Maintains Protective Efficacy in the Setting of Bacterial STIs: A Secondary Analysis of HPTN 083.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: September 16, 2024
Adolescent Girls and Young Women Overcoming Adherence Challenges with Vaginal and Oral PrEP Use: A Longitudinal Qualitative Study from a Crossover Trial in South Africa, Uganda, and Zimbabwe.
Journal: AIDS and behavior
Published: September 07, 2024
Analytical treatment interruption among women with HIV in southern Africa who received VRC01 or placebo in the Antibody Mediated Prevention Study: ATI stakeholder engagement, implementation and early clinical data.
Journal: Journal of the International AIDS Society
Published: August 10, 2024
Efficacy of the Dapivirine Vaginal Ring Accounting for Imperfect Adherence.
Journal: AIDS and behavior
Published: August 02, 2024
Correlates of Adherence to Oral and Vaginal Pre-exposure Prophylaxis (PrEP) Among Adolescent Girls and Young Women (AGYW) Participating in the MTN-034/REACH Trial.
Journal: AIDS and behavior
Published: May 15, 2024
Adolescent Girls and Young Women's Experiences with Disclosing Oral PrEP or Dapivirine Vaginal Ring Use: a Multi-Country Qualitative Analysis.
Journal: AIDS and behavior
Published: June 02, 2023
Last Updated: 09/26/2026